Intellia director granted RSUs and options
Intellia Therapeutics, Inc. director Fred E. Cohen received new equity-based compensation.
Rhea-AI Filing Summary
Intellia Therapeutics, Inc. director Fred E. Cohen received new equity-based compensation. He was granted 9,200 restricted stock units, each representing a contingent right to one share of Intellia common stock, increasing his direct common stock holdings to 216,653 shares.
He was also granted a stock option covering 13,300 shares of common stock at an exercise price of $12.89 per share. This option vests in full on the earlier of the first anniversary of the June 9, 2026 grant date or the next annual meeting of stockholders, and expires on June 8, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 22,500 shares
Grant/Award
2 txns
Insider
Cohen Fred E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 13,300 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 9,200 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 13,300 contracts (Direct);
Common Stock — 216,653 shares (Direct)
Footnotes (2)
- F1. Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- F2. This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
Key Figures
RSUs granted: 9,200 units
Option shares granted: 13,300 shares
Option exercise price: $12.89 per share
+2 more
5 metrics
RSUs granted
9,200 units
Restricted stock units granted June 9, 2026
Option shares granted
13,300 shares
Stock option grant June 9, 2026
Option exercise price
$12.89 per share
Stock option on 13,300 shares
Shares held after grant
216,653 shares
Common stock directly owned after RSU grant
Option expiration date
June 8, 2036
Expiry of 13,300-share stock option
Key Terms
restricted stock units, Stock Option (right to buy), exercise price, vests in full, +1 more
5 terms
restricted stock units financial
"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"Stock Option (right to buy) with respect to 13,300 shares of Common Stock"
exercise price financial
"conversion or exercise price of 12.8900 per share for the stock option"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vests in full financial
"This option was granted ... and vests in full on the earlier to occur of the first anniversary"
annual meeting of stockholders financial
"vests in full on the earlier to occur of the first anniversary or the date of the next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Intellia Therapeutics (NTLA) report for Fred E. Cohen?
Intellia reported that director Fred E. Cohen received equity awards, not open-market trades. He was granted 9,200 restricted stock units and a stock option for 13,300 shares, both dated June 9, 2026, as part of his compensation.
What stock option did Fred E. Cohen receive from Intellia Therapeutics (NTLA)?
Fred E. Cohen received a stock option for 13,300 shares of Intellia common stock at an exercise price of $12.89 per share. The option vests in full on the earlier of the first anniversary of the June 9, 2026 grant date or the next annual meeting.
When do Fred E. Cohen’s new Intellia (NTLA) stock options expire?
The new Intellia stock option granted to Fred E. Cohen expires on June 8, 2036. This long-dated option provides a right to buy 13,300 shares at $12.89 per share, once it fully vests according to the disclosed vesting schedule.
What are the restricted stock units granted to Fred E. Cohen by Intellia Therapeutics?
The filing states that 9,200 restricted stock units were granted, each representing a contingent right to receive one share of Intellia common stock. These units are a form of equity compensation that converts into shares when vesting conditions are satisfied.
Were Fred E. Cohen’s Intellia (NTLA) transactions open-market purchases or sales?
The transactions were not open-market trades. The Form 4 describes them as grants or awards, with zero purchase price per share, indicating compensation-related acquisitions of restricted stock units and stock options rather than market buying or selling.
AI-generated analysis. How Rhea-AI works. Not financial advice.
